Amarin Technologies SA

About Amarin Technologies SA

At Amarin we have specialized in the development and manufacturing of topical and transdermal products. With more than 30 years in the field we offer vast experience and know-how. We have carried out successful developments that are currently being commercialized in the main markets of the world (Fentanyl in EU, Rivastigmine and Buprenorphine in Latam and Diclofenac in the US).

...

Certifications
  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Contact info

Products from Amarin Technologies SA (3)

  • Buprenorphine Patch

    Product Buprenorphine Patch

    Amarin has developed a patch intended to be AB rated to Butrans®, but with the comparative advantages of having half of the drug content and also a reduced size (having less residual drug after 7 days of use). As the patch delivers the same amount of drug, this makes it more efficient.

    O...
  • Fentanyl Patch

    Product Fentanyl Patch

    Fentanyl is a synthetic analgesic related to phenylpiperidines, which interacts predominately with the opioid μ-receptor. Fentanyl primary actions are analgesia and sedation. Minimum effective analgesic serum concentrations of fentanyl in opioid naive patients range from 0.2 to 1.2 ng/mL, and side effects ...
  • Methylphenidate Patch

    Product Methylphenidate Patch

    Amarin patch is 33% smaller ant it also has one third less of the drug content. As the patch delivers the same amount of drug, this makes it 149% more efficient in comparison to the originator.

     Additionally, there has been multiple customers complains on Dyatrana due to backing ...

Amarin Technologies SA Resources (1)